Results 271 to 280 of about 216,147 (379)

Ethnomedicinal Uses, Phytochemistry, Pharmacological Activities, and Toxicology of the Subfamily Gomphrenoideae (Amaranthaceae): A Comprehensive Review

Chemistry &Biodiversity, Volume 22, Issue 9, September 2025.
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves, Giulia Cristina de Andreoli Souza, Alvaro Jose Hernandez Tasco, Marcos José Salvador   +3 more
wiley   +1 more source

Association between triglyceride-glucose index and incidence risk of gout: a nationwide cohort study. [PDF]

Sci Rep
Chang Y, Park JY, Song TJ.
europepmc   +1 more source

Febuxostat‐Induced Agranulocytosis: An Illustrative Case Report and Comprehensive Literature Review

Clinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Neutropenia induced by febuxostat is uncommon, with limited literature available to assess its frequency. This rare complication carries a serious risk to life. It is essential for healthcare providers to stay alert and informed about this potential adverse reaction.
Qiuping Liu, Bing Zhong
wiley   +1 more source

Are there rural-urban disparities in cardiovascular disease hospitalization and other outcomes in people with gout? A nationwide U.S. study. [PDF]

Rheumatology (Oxford)
Singh JA, Chandrupatla SR.
europepmc   +1 more source

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

Clinical Pharmacology &Therapeutics, Volume 118, Issue 3, Page 561-566, September 2025.
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson, D. Max Smith, Sony Tuteja, Jai N. Patel, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +4 more
wiley   +1 more source

Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system. [PDF]

Sci Rep
Zheng G, Lu M, Ouyang Y, Chen S, Hu B, Xu S, Sun G.   +6 more
europepmc   +1 more source

Global Burden of Disease Due to High Body Mass Index and Projections to 2040: A Study Based on the Global Burden of Disease Study 2019

The International Journal of Health Planning and Management, Volume 40, Issue 5, Page 1069-1082, September 2025.
ABSTRACT Background The prevalence of high body mass index (BMI) contributes to an increased risk of various diseases. This study aimed to identify global disease burden trends associated with high BMI from 1990 to 2019 and forecasts up to 2040. Methods Using data from the global burden of disease (GBD) 2019 study, we analysed the number and ratio of ...
Eun‐Ji Kim, Yoonseo Park, Sewon Park, Mihajlo Jakovljevic, Munjae Lee   +4 more
wiley   +1 more source

Hand function in gout: a comparative study with rheumatoid arthritis and healthy. [PDF]

Rev Assoc Med Bras (1992)
Mete O, Apaydin H, Varol F, Gülöksüz EGA, Pamukcu M.   +4 more
europepmc   +1 more source